دواعي استعمال روفيلاك 300مكجم/2مل سرنجة معبأة

Human anti-D (Rho(D)) immune globulin 300 mcg (1500 IU) prefilled syringe for suppression of Rh isoimmunization.

• Suppression of Rh isoimmunization in non-sensitized Rh(D)-negative patients.DailyMed (U.S. National Library of Medicine)
• Raising platelet counts in Rh(D)-positive, non-splenectomized adults with chronic immune thrombocytopenic purpura (ITP).الفئة: AdultsDailyMed (U.S. National Library of Medicine)

• Contraindicated after anaphylactic or severe systemic reaction to human immune globulin, and in IgA-deficient patients with anti-IgA antibodies and a history of hypersensitivity.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
• Contraindicated in the newborn infant of a mother who received Rhophylac postpartum.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)

• Boxed warning: intravascular hemolysis, sometimes fatal, has been reported in Rh(D)-positive patients treated for ITP; this does not apply to Rh(D)-negative patients treated for suppression of Rh isoimmunization.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)
• Anti-D administration can interfere with blood typing, antibody screening and direct antiglobulin (Coombs) tests, including in the newborn after antepartum dosing.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)

• Observe patients for at least 20 minutes following administration.نشرة دولية لنفس المنتج · DailyMed (U.S. National Library of Medicine)